OPKO Health
OPK
#6197
Rank
A$1.54 B
Marketcap
A$2.07
Share price
-1.33%
Change (1 day)
-2.06%
Change (1 year)

Earnings for OPKO Health (OPK)

Earnings in 2026 (TTM): -A$0.35 Billion

According to OPKO Health 's latest financial reports the company's current earnings are A$0.58 Billion. In 2025 the company made an earning of -A$0.34 Billion a decrease over its 2024 earnings that were of -A$14.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OPKO Health from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.35 Billion1.66%
2025 -A$0.34 Billion2229.09%
2024 -A$14.47 Million-94.38%
2023 -A$0.26 Billion-52.92%
2022 -A$0.55 Billion2691.58%
2021 -A$19.58 Million-128.81%
2020 A$67.95 M-115.96%
2019 -A$0.43 Billion72.03%
2018 -A$0.25 Billion-33.83%
2017 -A$0.38 Billion264.29%
2016 -A$0.11 Billion-46.71%
2015 -A$0.2 Billion-19.31%
2014 -A$0.24 Billion64.11%
2013 -A$0.15 Billion180.06%
2012 -A$51.95 Million53.56%
2011 -A$33.83 Million55.87%
2010 -A$21.71 Million-48.27%
2009 -A$41.95 Million-24.64%
2008 -A$55.67 Million-85.11%
2007 -A$0.38 Billion6.61%
2006 -A$0.36 Billion18539.02%
2005 -A$1.89 Million-32.33%
2004 -A$2.79 Million-45.53%
2003 -A$5.11 Million-64.7%
2002 -A$14.46 Million2.99%
2001 -A$14.04 Million16.9%
2000 -A$12.01 Million104.81%
1999 -A$5.87 Million40.03%
1998 -A$4.19 Million-0%
1997 -A$4.19 Million7.14%
1996 -A$3.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.26 B-11,447.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.35 B-3,654.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.19 B-2,352.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.39 B-4,291.82%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$1.91 B-700.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.21 B-479.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.16 B-1,091.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-A$80.88 Million-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA